IL-10 production from dendritic cells is associated with DC SIGN in human leprosy

Immunobiology

Volumn 218, Issue 12, 2013, Pages 1488-1496

  Kumar, Sudhir ^a   Naqvi, Raza Ali ^a   Bhat, Ajaz A ^a   Rani, Richa ^b   Ali, Riyasat ^a   Agnihotri, Abhishek ^a   Khanna, Neena ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

DC SIGN; Leprosy; ManLAM; Mycobacterium leprae; NF B; P300

Indexed keywords

CD209 ANTIGEN; CD83 ANTIGEN; E1A ASSOCIATED P300 PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE ACETYLTRANSFERASE PCAF; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; LIPOARABINOMANNAN; MANNOSE CAPPED LIPOARABINOMANNAN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CELL MATURATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTRACELLULAR SIGNALING; LEPROMATOUS LEPROSY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUBERCULOID LEPROSY; VALIDATION PROCESS;

DC SIGN; LEPROSY; MANLAM; MYCOBACTERIUM LEPRAE; NF-ΚB; P300;

ACETYLATION; ADOLESCENT; ADULT; ANTIBODIES, BLOCKING; ANTIGENS, CD; CELL ADHESION MOLECULES; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNE EVASION; INTERLEUKIN-10; INTERLEUKIN-4; LECTINS, C-TYPE; LEPROSY; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; NF-KAPPA B; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84885896195     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.05.004     Document Type: Article

References (34)

1. Aerts-Toegaert C., Heirman C., Tuyaerts S., Corthals J., Aerts J.L., Bonehill A., Thielemans K., Breckpot K. CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur. J. Immunol. 2007, 37:686-695.
2. Al-Bader T., Christodoulides M., Heckels J.E., Holloway J., Semper A.E., Friedmann P.S. Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitides. Infect. Immun. 2003, 71:5590-5597.
3. Barreiro L.B., Quach H., Krahenbuhl J., Khaliq S., Mohyuddin A., Mehdi S.Q., Gicquel B., Neyrolles O., Quintana-Murci L. DC-SIGN interacts with Mycobacterium leprae but sequence variation in this lectin is not associated with leprosy in the Pakistani population. Hum. Immunol. 2006, 67:102-107.
4. Bochud P.Y., Hawn T.R., Aderem A. A Toll-like receptor 2 polymorphism that is associated with lepromatous leprosyis unable to mediate mycobacterial signaling. J. Immunol. 2003, 170:3451-3454.
5. Caamaño J., Hunter C.A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 2002, 15:414-429.
6. Cao W., Lee S.H., Lu J. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem. J. 2005, 385:85-93.
7. Feinberg H., Mitchell D.A., Drickamer K., Weis W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 2001, 294:2163-2166.
8. Fukutomi Y., Matsuoka M., Minagawa F., Toratani S., McCormick G., Krahenbuhl J. IL-10 treatment of macrophages bolsters intracellular survival of Mycobacterium leprae. Int. J. Lepr. Other Mycobact. Dis. 2004, 72:16-26.
9. Gatfield J., Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 2000, 288:1647-1651.
10. Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B., Van Kooyk Y. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 2003, 197:7-17.
11. Gijzen K., Tacken P.J., Zimmerman A., Joosten B., de Vries I.J., Figdor C., Torensma G.R. Relevance of DC-SIGN in DC-induced T cell proliferation. J. Leukoc. Biol. 2007, 81:729-740.
12. Gringhuis S.I., den Dunnen J., Litjens M., van der Vlist M., Geijtenbeek T.B. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat. Immunol. 2009, 10:1081-1088.
13. Gringhuis S.I., den Dunnen J., Litjens M., van Het H.B., van Kooyk Y., Geijtenbeek T.B. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007, 26:605-616.
14. Kang T.J., Yeum C.E., Kim B.C., You E.Y., Chae G.T. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 2004, 112:674-680.
15. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003, 3:984-993.
16. Khare S., Bhutani L.K., Rao D.N. Modulation of peripheral blood derived monocytes/macrophages from leprosy patients using 'tuftsin' for production of reactive oxygen intermediates. Lepr. Rev. 1993, 64:208-218.
17. Krutzik S.R., Ochoa M.T., Sieling P.A., Uematsu S., Ng Y.W., Legaspi A., Liu P.T., Cole S.T., Godowski P.J., Maeda Y., Sarno E.N., Norgard M.V., Brennan P.J., Akira S., Rea T.H., Modlin R.L. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 2003, 9:525-532.
18. Kumar S., Naqvi R.A., Khanna N., Pathak P., Rao D.N. Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-β, CTLA-4 and Cbl-b. Clin. Immunol. 2011, 141:133-142.
19. Kumar S., Naqvi R.A., Khanna N., Rao D.N. Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy. Mol. Immunol. 2011, 48:1178-1190.
20. Lipscomb M.F., Masten B.J. Dendritic cells: immune regulators in health and disease. Physiol. Rev. 2002, 82:97-130.
21. Maldonado-García G., Chico-Ortiz M., Lopez-Marin L.M., Sánchez-García F.J. High-polarity Mycobacterium avium derived lipids interact with murine macrophage lipid rafts. Scand. J. Immunol. 2004, 60:463-470.
22. Mũnoz S., Rivas-Santiago B., Enciso J.A. Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains. Scand. J. Immunol. 2009, 70:256-263.
23. Pasqualucci L., Dominguez-Sola D., Chiarenza A., Fabbri G., Grunn A., Trifonov V., Kasper L.H., Lerach S., Tang H., Ma J., Rossi D., Chadburn A., Murty V.V., Mullighan C.G., Gaidano G., Rabadan R., Brindle P.K., Dalla-Favera R. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011, 471:189-195.
24. Quivy V., Van Lint C. Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem. Pharmacol. 2004, 68:1221-1229.
25. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity: a five-group system. Int. J. Lepr. Other Mycobact. Dis. 1966, 34:255-273.
26. Rutella S., Danese S., Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006, 108:1435-1440.
27. Schenk M., Krutzik S.R., Sieling P.A., Lee D.J., Teles R.M., Ochoa M.T., Komisopoulou E., Sarno E.N., Rea T.H., Graeber T.G., Kim S., Cheng G., Modlin R.L. NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat. Med. 2012, 18:555-563.
28. Schjetne K.W., Thompson K.M., Aarvak T., Fleckenstein B., Sollid L.M., Bogen B. A mouse C kappa specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation. Int. Immunol. 2002, 14:1423-1430.
29. Scollard D.M., Adams L.B., Gillis T.P., Krahenbuhl J.L., Truman R.W., Williams' D.L. The continuing challenges of leprosy. Clin. Microbiol. Rev. 2006, 19:338-381.
30. Sieling P.A., Abrams J.S., Yamamura M., Salgame P., Bloom B.R., Rea T.H., Modlin R.L. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J. Immunol. 1993, 150:5501-5510.
31. Soilleux E.J., Sarno E.N., Hernandez M.O., Moseley E., Horsley J., Lopes U.G., Goddard M.J., Vowler S.L., Coleman N., Shattock R.J., Sampaio E.P. DC-SIGN association with the Th2 environment of lepromatous lesions: cause or effect?. J. Pathol. 2006, 209:182-189.
32. Sridevi K., Khanna N., Chattree V., Pal P.C., Haq W., Rao D.N. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposome delivery. Int. Immunopharmacol. 2003, 3:1589-1600.
33. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001, 107:7-11.
34. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1998, 1:661-671.